Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Urinary Bladder Neoplasms × Synapsins × 30 days × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1

Interventions

Gemcitabine 15 Specimen Handling 13 Magnetic Resonance Spectroscopy 12 pembrolizumab 11 Cisplatin 10 durvalumab 7 Nivolumab 6 Cystoscopy 6 Docetaxel 5 avelumab 4 atezolizumab 4 Transurethral Resection of Bladder 4 Radiotherapy 4 Radiation 4 Paclitaxel 4 Mitomycin 4 Carboplatin 4 Biopsy 4 erdafitinib 3 enfortumab vedotin 3 cabozantinib 3 Standard of Care 3 Ipilimumab 3 Immunoglobulin G 3 Fluorouracil 3 Disulfides 3 CTLA-4 Antigen 3 sacituzumab govitecan 2 eribulin 2 dehydroftorafur 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07332351 2026-03-13

TRIFECTA

University of Washington

Phase 2 Not yet recruiting

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡